| Year |
Citation |
Score |
| 2016 |
Bourdeau A, Van Slyke P, Kim H, Cruz M, Smith T, Dumont DJ. Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease. Bmc Research Notes. 9: 289. PMID 27236199 DOI: 10.1186/S13104-015-1817-1 |
0.314 |
|
| 2013 |
Bourdeau A, Trop S, Doody KM, Dumont DJ, Tremblay ML, Tremblayef ML. Inhibition of T cell protein tyrosine phosphatase enhances interleukin-18-dependent hematopoietic stem cell expansion. Stem Cells (Dayton, Ohio). 31: 293-304. PMID 23135963 DOI: 10.1002/Stem.1276 |
0.316 |
|
| 2009 |
Heinonen KM, Bourdeau A, Doody KM, Tremblay ML. Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-gamma signaling. Proceedings of the National Academy of Sciences of the United States of America. 106: 9368-72. PMID 19474293 DOI: 10.1073/Pnas.0812109106 |
0.328 |
|
| 2009 |
Doody KM, Bourdeau A, Tremblay ML. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunological Reviews. 228: 325-41. PMID 19290937 DOI: 10.1111/J.1600-065X.2008.00743.X |
0.341 |
|
| 2008 |
Trop S, Tremblay ML, Bourdeau A. Modulation of bone marrow-derived endothelial progenitor cell activity by protein tyrosine phosphatases. Trends in Cardiovascular Medicine. 18: 180-6. PMID 18790388 DOI: 10.1016/J.Tcm.2008.07.001 |
0.369 |
|
| 2006 |
Sirois J, Côté JF, Charest A, Uetani N, Bourdeau A, Duncan SA, Daniels E, Tremblay ML. Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development. Mechanisms of Development. 123: 869-80. PMID 17070019 DOI: 10.1016/J.Mod.2006.08.011 |
0.371 |
|
| 2006 |
Simoncic PD, Bourdeau A, Lee-Loy A, Rohrschneider LR, Tremblay ML, Stanley ER, McGlade CJ. T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation. Molecular and Cellular Biology. 26: 4149-60. PMID 16705167 DOI: 10.1128/Mcb.01932-05 |
0.322 |
|
| 2006 |
Heinonen KM, Dubé N, Bourdeau A, Lapp WS, Tremblay ML. Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling. Proceedings of the National Academy of Sciences of the United States of America. 103: 2776-81. PMID 16477024 DOI: 10.1073/Pnas.0508563103 |
0.314 |
|
| 2005 |
Dubé N, Bourdeau A, Heinonen KM, Cheng A, Loy AL, Tremblay ML. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development. Cancer Research. 65: 10088-95. PMID 16267035 DOI: 10.1158/0008-5472.Can-05-1353 |
0.333 |
|
| 2005 |
Bourdeau A, Dubé N, Tremblay ML. Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Current Opinion in Cell Biology. 17: 203-9. PMID 15780598 DOI: 10.1016/J.Ceb.2005.02.001 |
0.301 |
|
| 2004 |
Chan NL, Bourdeau A, Vera S, Abdalla S, Gross M, Wong J, Cymerman U, Paterson AD, Mullen B, Letarte M. Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin. Placenta. 25: 208-17. PMID 14972453 DOI: 10.1016/S0143-4004(03)00181-4 |
0.588 |
|
| 2004 |
Persson C, Sävenhed C, Bourdeau A, Tremblay ML, Markova B, Böhmer FD, Haj FG, Neel BG, Elson A, Heldin CH, Rönnstrand L, Östman A, Hellberg C. Site-Selective Regulation of Platelet-Derived Growth Factor β Receptor Tyrosine Phosphorylation by T-Cell Protein Tyrosine Phosphatase Molecular and Cellular Biology. 24: 2190-2201. PMID 14966296 DOI: 10.1128/Mcb.24.5.2190-2201.2004 |
0.322 |
|
| 2001 |
Cho SK, Bourdeau A, Letarte M, Zúñiga-Pflücker JC. Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood. 98: 3635-42. PMID 11739167 DOI: 10.1182/Blood.V98.13.3635 |
0.53 |
|
| 2001 |
Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, Letarte M. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. The American Journal of Pathology. 158: 2011-20. PMID 11395379 DOI: 10.1016/S0002-9440(10)64673-1 |
0.601 |
|
| 2000 |
Bourdeau A, Faughnan ME, Letarte M. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Trends in Cardiovascular Medicine. 10: 279-85. PMID 11343967 DOI: 10.1016/S1050-1738(01)00062-7 |
0.614 |
|
| 2000 |
Matsubara S, Bourdeau A, terBrugge KG, Wallace C, Letarte M. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Stroke; a Journal of Cerebral Circulation. 31: 2653-60. PMID 11062290 DOI: 10.1161/01.Str.31.11.2653 |
0.611 |
|
| 2000 |
Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, Guttmacher AE, Becker L, Letarte M. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. The American Journal of Pathology. 156: 911-23. PMID 10702408 DOI: 10.1016/S0002-9440(10)64960-7 |
0.597 |
|
| 2000 |
Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI, Dunn J, Letarte M. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatric Research. 47: 24-35. PMID 10625079 DOI: 10.1203/00006450-200001000-00008 |
0.615 |
|
| 1999 |
Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. The Journal of Clinical Investigation. 104: 1343-51. PMID 10562296 DOI: 10.1172/Jci8088 |
0.621 |
|
| 1997 |
Pichuantes S, Vera S, Bourdeau A, Pece N, Kumar S, Wayner EA, Letarte M. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens. 50: 265-76. PMID 9331949 DOI: 10.1111/J.1399-0039.1997.Tb02870.X |
0.563 |
|
| Show low-probability matches. |